Skip to content
OpenCapital
Get started

Arcadia Biosciences RKDA Q4 2024 Annual earnings

Reported March 20, 2025 · After market close

Revenue$1.2MBeat by $66.0K
EPS-$2.48Miss by $1.59
Revenue estimate$1.2M
EPS estimate-$0.89

Next report

Aug 19, 2026 (In 2 weeks)
Revenue estimate$1.9M
EPS estimate-$0.56

Versus estimates

Revenue

Q1 2026$1.1MMiss by $500.0KQ4 2025$901.0KMiss by $499.0KQ3 2025$1.3MMiss by $598.0KQ2 2025$1.5MMiss by $745.0KQ1 2025$1.2MMiss by $100.0K
Q4 2024$1.2MBeat by $66.0K

Diluted EPS

Q1 2026-$2.11Miss by $1.31Q4 2025-$0.98Miss by $0.32Q3 2025$0.62Beat by $1.16Q2 2025$0.02Beat by $0.81Q1 2025$1.90Beat by $2.88
Q4 2024-$2.48Miss by $1.59

Ask the moment Arcadia Biosciences reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

When did Arcadia Biosciences report Q4 2024 earnings?
Arcadia Biosciences (RKDA) reported Q4 2024 earnings on March 20, 2025 after market close.
What were Arcadia Biosciences's Q4 2024 revenue and EPS?
Arcadia Biosciences reported revenue of $1.2M and eps of $-2.48 for Q4 2024.
Did Arcadia Biosciences beat estimates in Q4 2024?
Revenue beat the consensus estimate of $1.2M by $66.0K. EPS missed the consensus estimate of $-0.89 by $1.59.
Where can I find Arcadia Biosciences's Q4 2024 SEC filings?
You can read the 10-K periodic report (0000950170-25-044487) directly on SEC EDGAR. The filing index links above go to sec.gov.